Recent Updates
Recently added Catalysts
ACB Positive Sentiment Score: 75/100

Aurora Cannabis Announces Results of 2023 Annual General Meeting NASDAQ | TSX

Key Takeaway: Aurora Cannabis announced the results of its 2023 Annual General Meeting held virtually on August 14, 2023. Shareholders approved all resolutions presented, including the election of directors and the appointment of KPMG LLP as auditors. The meeting saw a turnout of 92,897,315 shares, representing 26.23% of the company's outstanding common shares. Aurora continues its focus on cannabis for both medical and consumer markets, maintaining a varied brand portfolio.

Market Sentiment Analysis

POSITIVE FACTORS

  • All matters presented at the Annual General Meeting were approved.
  • Shareholder turnout was relatively high, with over 26% of shares represented.
  • The election of directors saw significant support with many nominees receiving over 75% of the votes.

Full Press Release Details

Aurora Cannabis Announces Results of 2023 Annual
EDMONTON, AB, Aug. 14, 2023 /CNW/ - Aurora Cannabis
Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to
cannabis, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting") held
today, Monday, August 14, 2023 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy
at the Meeting was 92,897,315, representing 26.23% of Aurora's issued and outstanding common shares as of the record date.
All of the matters put forward before shareholders
for consideration and approval, as set out in the Company's Management Information Circular dated June 30, 2023, were approved by the
requisite majority of votes cast at the Meeting. The details of the voting results for the election of directors are set out below:
Nominee Votes For Votes Withheld
Ron Funk 21,456,189 (78.91 %) 5,734,650 (21.09 %)
Miguel Martin 23,182,258 (85.26 %) 4,009,014 (14.74 %)
Michael Singer 23,195,268 (85.30 %) 3,996,005 (14.70 %)
Norma Beauchamp 23,040,789 (84.74 %) 4,150,484 (15.26 %)
Theresa Firestone 20,769,802 (76.38 %) 6,421,470 (23.62 %)
Adam Szweras 23,765,335 (87.40 %) 3,425,938 (12.60 %)
Chitwant Kohli 20,600,774 (75.76 %) 6,590,064 (24.24 %)
Shareholders also approved the following matters:
setting the size of the Board
at seven (7) directors;
a non-binding advisory resolution
on the Company's approach to executive compensation; and
the appointment of KPMG LLP as
auditors of the Company for the ensuing year.
The Company has filed a report of voting results on
all resolutions voted on at the Meeting under its profile on www.sedarplus.com.
Aurora is opening the world to cannabis, serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people
improve their lives. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and
Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands,
Pedanios, Bidiol and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated
agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to
break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan", "continue", "expect", "project",
"intend", "believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur.
These forward-looking statements are only predictions.
Forward looking information or statements contained in this news release have been developed based on assumptions management considers
to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from market research and industry analysis and on assumptions based on data
and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events,
results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking
statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure
to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and
retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand
in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration
of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability
to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield
from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes
in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of
COVID-19, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information
form dated June 14, 2023 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile
on SEDAR at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of
risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results.
Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are
cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or
obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except
as expressly required by applicable securities law.
SOURCE Aurora Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2023/14/c7737.html
For further information: For Media: Michelle Lefler, VP, Communications
& PR, media@auroramj.com; For Investors: ICR, Inc., Investor Relations, aurora@icrinc.com
CO: Aurora Cannabis Inc.
CNW 17:30e 14-AUG-23

Frequently Asked Questions

What date was the Aurora Cannabis Annual General Meeting held?

The Aurora Cannabis Annual General Meeting was held on August 14, 2023.

What percentage of shares were represented at the meeting?

92,897,315 shares were represented, totaling 26.23% of outstanding shares.

Who was appointed as the auditors for the next year?

KPMG LLP was appointed as auditors for the ensuing year.

How many directors were approved for the Aurora Board?

The size of the Board was set at seven directors.

What brands are under Aurora Cannabis?

Aurora's brands include Aurora Drift, MedReleaf, San Rafael '71, and more.

Last updated: Aug 14, 2023